Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

FDA Reports Patient Deaths with Radiofrequency Ablation to Lung Tumors
Author
Howard (Jack) West, MD

This week, the US FDA made a public announcement to alert the public that it had received reports of several patient deaths from the technique of radiofrequency ablation (RFA) to lung tumors. This is an investigational technique that I described in a prior post, after several members asked about RFA. I made the point that while it was an option to consider, it was still early in development and was not an option that I thought would be a leading option except in very unusual circumstances. You heard it here first...

There have been some individuals and centers that have been liberal in their marketing of this technique, including for lung tumors. The FDA warning highlights the danger of marketing hype getting ahead of the evidence supporting the safety and clinical benefit of a new technique or drug, which really need to be subjected to thorough clinical testing. These trials are well regulated and closely monitored, and their results will move the field forward. Accordingly, the FDA warning mentions that RFA should preferably be conducted on lung tumors in the setting of a clinical trial.

Next Previous link

Previous PostNext Post

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on